Hydroxychloroquine in Hospitalized Patients with COVID-19: Real-World Experience Assessing Mortality.

Frank H Annie Cristian SirbuKeely R FrazierMike Broce B Daniel Lucas

Published in: Pharmacotherapy (2020)

We report from a large retrospective multinational database analysis of COVID-19 outcomes with HCQ and overall mortality in hospitalized patients. There was no statistically significant increase in mortality and mortality-arrhythmia with HCQ or HCQ-AZ.

Keyphrases

cardiovascular events
risk factors
coronavirus disease
sars cov
emergency department
cardiovascular disease
skeletal muscle